All Pharma News
Valbiotis Presents the Full Results of the Phase II/III REVERSE-IT Study

Valbiotis Presents the Full Results of the Phase II/III REVERSE-IT Study
ACCESSWIRE
11 Sep 2023
Share Share
Valbiotis Announces the Large Success of Phase II/III Study on TOTUM•63

Valbiotis Announces the Large Success of Phase II/III Study on TOTUM•63
BUSINESSWIRE
22 May 2023
Share Share
Valbiotis Publishes Its 2022 Annual Results

Valbiotis Publishes Its 2022 Annual Results
BUSINESSWIRE
15 Mar 2023
Share Share
Valbiotis Announces Positive Results in Bioavailability and Mode of Action TOTUM

Valbiotis Announces Positive Results in Bioavailability and Mode of Action TOTUM
BUSINESSWIRE
30 Jan 2023
Share Share
Valbiotis: a Pivotal Year in the Execution of Its Clinical & Commercial Strategy

Valbiotis: a Pivotal Year in the Execution of Its Clinical & Commercial Strategy
BUSINESSWIRE
10 Jan 2023
Share Share
Valbiotis Successfully Completes a Fundraise of 9.7 Million Euros

Valbiotis Successfully Completes a Fundraise of 9.7 Million Euros
BUSINESSWIRE
09 Nov 2022
Share Share
Valbiotis Accelerates Its Marketing Strategy

Valbiotis Accelerates Its Marketing Strategy
BUSINESSWIRE
07 Oct 2022
Share Share
Valbiotis Publishes Its Financial Report for the First Half of 2022

Valbiotis Publishes Its Financial Report for the First Half of 2022
BUSINESSWIRE
15 Sep 2022
Share Share
Frédéric PELONG, Chief Financial Officer, Joins the Valbiotis Board of Directors

Frédéric PELONG, Chief Financial Officer, Joins the Valbiotis Board of Directors
BUSINESSWIRE
05 Sep 2022
Share Share
Valbiotis Announces First Visit of First Patient in TOTUM•63 MOA Clinical Study

Valbiotis Announces First Visit of First Patient in TOTUM•63 MOA Clinical Study
BUSINESSWIRE
28 Apr 2022
Share Share